Early and Aggressive Initiation of Insulin Therapy for Type 2 Diabetes: What Is the Evidence?
Author:
- Kevin NiswenderKNKevin Niswender
Open Access
- 1 April 2009
- journal article
- Published by American Diabetes Association in Clinical Diabetes
- Vol. 27 (2) , 60-68
Abstract
IN BRIEF: Type 2 diabetes is a progressive disease in which b[beta symbol]-cell function continually declines and eventually fails, ultimately requiring nearly all patients to be placed on insulin therapy. An increasing body of evidence suggests that early intensive glycemic control reduces long-term vascular outcomes and potentially may prolong b[beta symbol]-cell lifespan and function. Herein, evidence in favor of early insulin therapy on disease progression and long-term outcomes will be reviewed and placed into clinical context.Keywords
This publication has 45 references indexed in Scilit:
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2009
- Standards of Medical Care in Diabetes—2009Diabetes Care, 2009
- Importance of Postprandial Glucose Levels as a Target for Glycemic Control in Type 2 DiabetesSouthern Medical Journal, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetesDiabetologia, 2008
- Towards peakless, reproducible and long‐acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studiesDiabetes, Obesity and Metabolism, 2007
- Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4‐year follow‐upDiabetes, Obesity and Metabolism, 2007
- Delay Of Insulin Addition To Oral Combination Therapy Despite Inadequate Glycemic ControlJournal of General Internal Medicine, 2007
- Islet cell failure in type 2 diabetesJournal of Clinical Investigation, 2006
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998